Ropack Spring Show Guide - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ropack Spring Show Guide


Ropack provides contract packaging and manufacturing services for more than 90 U.S., Canadian and European pharmaceutical and consumer healthcare customers. Flexible, responsive and competitive, we focus on reliably accelerating the go-to-market timeline. Our 250,000 square feet of production, warehousing and distribution space includes a 15,000-square-foot, $9M facility for stick-pack packaging of humidity- and temperature-sensitive products. Because of taste-masking and convenience – without compromising integrity – stick-pack is ideal for uni-dose pediatric powders.

E-mail: Paul.dupont@ropack.com

Website: www.ropack.com

Shows attending:

  • BIO — Quebec Pavilion
  • INTERPHEX — booth 1166
  • AAPS Biotech — booth 3649

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here